Cargando…
Parvovirus B19‐induced severe anemia in heart transplant recipients: Case report and review of the literature
We report a case of a 64‐year‐old woman who developed transfusion‐dependent anemia after cardiac transplantation, the etiology of which was unknown after initial comprehensive evaluation. At the suggestion of the Transplant Infectious Diseases consultant, microbial agents with red blood cell tropism...
Autores principales: | Pinto, Natalia C., Newman, Clarissa, Gomez, Carlos A., Khush, Kiran K., Moayedi, Yasbanoo, Lee, Roy, Teuteberg, Jeffrey J., Montoya, Jose G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850585/ https://www.ncbi.nlm.nih.gov/pubmed/30776137 http://dx.doi.org/10.1111/ctr.13498 |
Ejemplares similares
-
Ethnic disparities in cardiac transplantation: opportunities to improve long-term outcomes in all cardiac transplant recipients
por: Kobulnik, Jeremy, et al.
Publicado: (2019) -
Parvovirus B19-induced severe anemia in heart transplant recipient: A case report
por: Xu, Bijun, et al.
Publicado: (2021) -
Parvovirus B19 Infection and Severe Anemia in Renal Transplant Recipients
por: Carraturo, Antonio, et al.
Publicado: (2012) -
2731. Posa-bly the Better Option? Comparison of Posaconazole vs. Itraconazole for Antifungal Prophylaxis After Heart Transplantation
por: Drucker, Darra, et al.
Publicado: (2023) -
(653) Tixagevimab and Cilgavimab Reduced the Likelihood of Covid after Heart Transplant in the Age of Omicron
por: Lee, R., et al.
Publicado: (2023)